TMEM17
Transmembrane protein 17
Also known as: FLJ34583, TMM17_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86X19
- Gene
- TMEM17
- Ensembl
- ENSG00000186889
- Chromosome
- 2
- Canonical length
- 198 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus,Actin filaments
OverviewNCBI Gene
Involved in non-motile cilium assembly. Predicted to be located in ciliary membrane. Predicted to be part of MKS complex. Predicted to be active in ciliary transition zone. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
198 residues, UniProt reviewed canonical sequence.
>Q86X19|TMEM17
1 MELPDPVRQR LGNFSRAVFS DSNRTGPESN EGPENEMVSS LALQMSLYFN TYYFPLWWVS
61 SIMMLHMKYS ILPDYYKFIV ITVIILITLI EAIRLYLGYV GNLQEKVPEL AGFWLLSLLL
121 QLPLILFLLF NEGLTNLPLE KAIHIIFTLF LAFQVVAAFL TLRKMVNQLA VRFHLQDFDR
181 LSANRGDMRR MRSCIEEILocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM17 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 11 nTPM
- basal ganglia: 7.6 nTPM
- choroid plexus: 7.3 nTPM
- parathyroid gland: 5.7 nTPM
- hippocampal formation: 4.9 nTPM
- adrenal gland: 4.7 nTPM
Single-cell type
- early primary spermatocytes: 40 nCPM
- epididymal efferent duct ciliated cells: 24 nCPM
- fallopian tube ciliated cells: 23 nCPM
- respiratory ciliated cells: 23 nCPM
- platelets: 23 nCPM
- other brain neurons: 22 nCPM
Immune cell
- plasmacytoid DC: 1.9 nTPM
- basophil: 0.5 nTPM
- myeloid DC: 0.5 nTPM
- neutrophil: 0.5 nTPM
- total PBMC: 0.4 nTPM
- NK-cell: 0.3 nTPM
Brain region
- hypothalamus: 20 nTPM
- pons: 12 nTPM
- midbrain: 12 nTPM
- choroid plexus: 10 nTPM
- medulla oblongata: 9.7 nTPM
- hippocampal formation: 9.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.26
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMEM17 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM17 as an antibody target. Whether an autoantibody or antibody against TMEM17 could matter depends on whether native TMEM17 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM17 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM17 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...